Atp - collagenik (syner collagen) - 120 caps

Collagen Regeneration Formula. 79% more effective than glucosamine. *

• Helps to reduce joint pain associated with osteoarthritis.*
• Helps to produce and repair connective tissue.*
• Helps to form red blood cells. A factor in the maintenance of good health.*
• Helps the body to metabolize fats.*
• Helps the body to metabolize proteins.*
• Helps the development and maintenance of bones.*
• Helps in the development and maintenance of cartilage.*
• Helps in the development and maintenance of teeth.*
• Helps in the development and maintenance of gums.*
• Helps in wound healing.*

Recommended Use or Purpose

A unique and powerful formula for type 1 and 2 collagen regeneration of the skin, tendons, cartilages, ligaments, bones, muscles and of any connective tissues. Anti-inflammatory, it also slows down the ageing process of connective tissues.

Recommended Dosage

Adults: Take 2 capsules three times a day with your meals. Consult a health professional for a use of over 3 months.

Caution

If symptoms persist or worsen, consult a health professional. Also if you are pregnant or breastfeeding, consult prior to using the product.

Allergy: Contains a by-product of chicken eggs.

*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

Medicinal Ingredients

Per 6 capsules

Hydrolysed collagen (Bovine) 2500 mg
UC-II®*, undenatured type II collagen. (chicken) 40 mg (providing 10 mgs undenatured type II collagen) per day / 10 mg
Deer antler velvet 200 mg
Chelated copper 500 mcg
Vitamin C (Sodium ascorbate) 250 mg
Silica (Bamboo extract 70%) 50 mg
Gotu kola (10% asiaticoside) 500 mg
NEM (natural egg shell membrane) 500 mg (glycosaminoglycans)

Non-Medicinal Ingredients: Brown rice powder

UC-II® is a standardized, undenatured (native) type-II collagen complex containing 25% undenatured type-II collagen. (U.S. Patents 7,083,820, 7,846,487 and EPO Patent EP1435906B1; Canadian patent CA 2459981C; and Japanese patent JP 4800574B2)